HomeAPRE • NASDAQ
add
Aprea Therapeutics Inc
Previous close
$1.83
Day range
$1.86 - $2.01
Year range
$1.41 - $5.70
Market cap
10.29M USD
Avg Volume
26.38K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 162.46K | -57.31% |
Operating expense | 4.25M | 120.12% |
Net income | -3.93M | -39.95% |
Net profit margin | -2.42K | -227.83% |
Earnings per share | — | — |
EBITDA | -4.08M | -29.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 19.28M | -40.45% |
Total assets | 20.22M | -39.09% |
Total liabilities | 3.36M | 13.36% |
Total equity | 16.86M | — |
Shares outstanding | 5.51M | — |
Price to book | 0.65 | — |
Return on assets | -46.22% | — |
Return on capital | -54.50% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.93M | -39.95% |
Cash from operations | -3.63M | 7.74% |
Cash from investing | — | — |
Cash from financing | 55.85K | -99.62% |
Net change in cash | -3.57M | -133.20% |
Free cash flow | -2.38M | 22.96% |
About
Website
Employees
8
